Davelizomib
Davelizomib is proteasome inhibitor with antineoplastic effect[1].
Product Specifications
CAS Number
2409841-51-4
UNSPSC
12352005
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/davelizomib.html
Solubility
10 mM in DMSO
Smiles
CC(C)C[C@@H](B1O[C@H](C(O1)=O)CC(O)=O)NC(CNC([C@H]2N(C3=C(C=C(C=C3)F)F)CC2)=O)=O
Molecular Formula
C21H26BF2N3O7
Molecular Weight
481.25
References & Citations
[1]Xiong, et al. Preparation and medicinal application of borates of azetidine derivatives. World Intellectual Property Organization, WO2020025037 A1. 2020-02-06.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC427900 20 µg
C19orf77 (SMIM24) (NM_001136503) Human Over-expression Lysate
Sign In for Pricing
View Details 
